AEGiS-DMG: HIV/Aids Drugs for Mpumalanga Daily Mail & GuardianImportant note: Information in this article was accurate in 2002. The state of the art may have changed since the publication date.
Click here to return to Daily Mail & Guardian main menu
DonateNow


HIV/Aids Drugs for Mpumalanga

Mail & Guardian (Johannesburg) - October 4, 2002
Nawaal Deane


The Mpumalanga Department of Health announced last week that it has begun a programme to prevent mother-to-child-transmission of HIV, days after the Mail & Guardian exposed provincial inaction in complying with a court order to provide anti-retroviral drugs to HIV-positive pregnant women.

Mpumalanga has one of the highest rates of HIV prevalence in South Africa. The province has been a thorn in the side of the Treatment Action Campaign (TAC), which won the Constitutional Court ruling ordering all provinces to provide the therapy.

Nonkosi Khumalo, spokesperson for the TAC, said that days after the M&G published the article the Mpumalanga health department told the TAC it had begun its programme in three main hospitals.

"This week one of the hospitals, Rob Ferreira, received its first supply of nevirapine," Khumalo said.

She said Mpumalanga should be acknowledged for finally complying with the court order.

The Eastern Cape announced on September 27 that R14-million had been allocated for its mother-to-child anti-retroviral programme over the next three years.

Provincial health officials have met the TAC to discuss training staff.

"The Eastern Cape needs lots of support. It is difficult to train healthcare workers because the province is so vast," Khumalo said.

"We will play a supportive role for those provinces that need assistance to roll out their programmes," she said.

Khumalo said the TAC was waiting for Limpopo, Free State and North West to respond to letters the group's lawyers had sent to provincial health departments.


021004
MG021002


Copyright © 2002 - Daily Mail & Guardian. For information about the content or for permission to redistribute, publish or use for broadcast, contact the publisher.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .